Extended recombinant polypeptides and compositions comprising same
US10961287B2 · kind B2 · utility
4Cited by
171References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2018 |
| Grant date | Mar 30, 2021 |
| Priority date | — |
| Expiry date | Feb 2, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions comprising biologically active proteins linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of using such compositions in treatment of glucose-related diseases, metabolic diseases, coagulation disorders, and growth hormone-related disorders and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.